Why is Solara Active falling/rising?

As of 11-Jun, Solara Active Pharma Sciences Ltd is experiencing a price increase, currently at Rs 512.55, reflecting a rise of Rs 38.05 or 8.02%. The stock has outperformed its sector today by 7.16%, reaching an intraday high of Rs 519, which is a 9.38% increase. Over the past week, the stock has shown a return of 8.13%, while its performance over the last year stands at 17.36%, significantly higher than the BSE 500's return of 5.98%. The company has reported positive results for the last three consecutive quarters, with a notable growth in profit after tax and a high return on capital employed, contributing to its attractive valuation compared to peers. However, concerns remain regarding its long-term fundamental strength, including a negative CAGR growth in operating profits over the past five years and a high debt to EBITDA ratio.
In the broader market context, the stock's recent performance has been strong relative to the benchmark, particularly in the short term, where it has outpaced the Sensex's 1-week return of 1.87%. The rising investor participation, indicated by an increase in delivery volume, suggests growing confidence among investors. However, the high percentage of pledged promoter shares could pose risks in a declining market, potentially exerting downward pressure on the stock price. Despite these challenges, the stock's recent upward movement is primarily driven by its strong quarterly results and attractive valuation metrics, which have resonated positively with investors.